Apollon Wealth Management LLC Has $2.61 Million Stake in Zoetis Inc. $ZTS

Apollon Wealth Management LLC increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 56.9% during the 2nd quarter, Holdings Channel reports. The fund owned 16,706 shares of the company’s stock after buying an additional 6,057 shares during the quarter. Apollon Wealth Management LLC’s holdings in Zoetis were worth $2,605,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Fifth Third Wealth Advisors LLC boosted its stake in Zoetis by 9.4% during the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 9,323 shares of the company’s stock worth $1,454,000 after acquiring an additional 802 shares during the last quarter. Fulcrum Capital LLC boosted its stake in Zoetis by 7.3% during the 2nd quarter. Fulcrum Capital LLC now owns 56,393 shares of the company’s stock worth $8,794,000 after acquiring an additional 3,847 shares during the last quarter. Summit Place Financial Advisors LLC boosted its stake in Zoetis by 0.8% during the 2nd quarter. Summit Place Financial Advisors LLC now owns 19,293 shares of the company’s stock worth $3,009,000 after acquiring an additional 149 shares during the last quarter. Aberdeen Group plc boosted its stake in Zoetis by 5.4% during the 2nd quarter. Aberdeen Group plc now owns 1,155,604 shares of the company’s stock worth $179,720,000 after acquiring an additional 59,245 shares during the last quarter. Finally, Davis Rea LTD. boosted its stake in Zoetis by 96.6% during the 2nd quarter. Davis Rea LTD. now owns 41,239 shares of the company’s stock worth $6,431,000 after acquiring an additional 20,268 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the topic of several recent analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and cut their price target for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Stifel Nicolaus lowered shares of Zoetis from a “buy” rating to a “hold” rating and cut their price target for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. Piper Sandler lifted their price target on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Finally, Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $196.71.

Zoetis Price Performance

NYSE ZTS opened at $141.05 on Monday. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 12-month low of $139.34 and a 12-month high of $196.55. The company has a market capitalization of $62.51 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 2.26 and a beta of 0.90. The firm’s 50 day moving average is $149.24 and its 200-day moving average is $154.33.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period last year, the company earned $1.56 earnings per share. The firm’s revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be issued a $0.50 dividend. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis’s dividend payout ratio (DPR) is 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.